Skip to main content
Clinical Trials/NCT05560854
NCT05560854CompletedNot Applicable

A Feasibility Study of Internet Delivered Prolonged Exposure for Patients Wit Post-traumatic Stress Disorder

Karolinska Institutet1 site in 1 country30 target enrollmentStarted: October 18, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
Number of drop-outs from treatment

Study Overview

Brief Summary

The primary objective with this study is to investigate the feasibility and acceptability of ten weeks of internet delivered prolonged exposure delivered through a digital platform with therapist support. The secondary objective is to investigate preliminary effects of internet delivered prolonged exposure in terms of reducing symptoms of post-traumatic stress, depression and increase quality of life.

Detailed Description

The investigators will investigate internet delivered prolonged exposure delivered as a ten-week treatment comprising of six modules (psychoeducation/rational, in vivo exposure, imaginal exposure, common problems during exposure, hot spots and relapse prevention). The feasibility and acceptability and preliminary effects of treatment- and assessment procedures will be evaluated using a within-group design with repeated measurements and qualitative interviews. Recruitment is designed to be broadly inclusive with minimal exclusion criteria. Patients will be recruited from a psychiatric clinic specialized in PTSD in Stockholm, Sweden and by advertisements in newspapers and social media.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Currently primary diagnosis PTSD according to DSM-5 diagnostic criteria for PTSD
  • •≥ 18 years
  • •Fluent in Swedish
  • •Signed informed consent

Exclusion Criteria

  • •PTSD is not the primary concern
  • •Initiation or adjustment of any psychotropic medication within the last 4 weeks prior to commencement of treatment
  • •Ongoing substance dependence
  • •Current suicide risk meriting crisis intervention
  • •Psychotic disorder
  • •Ongoing trauma-focused psychological treatment
  • •Ongoing trauma-related threat (e.g. living with a violent spouse)

Arms & Interventions

Internet delivered prolonged exposure

Experimental

Internet delivered prolonged exposure for ten weeks with therapist support.

Intervention: Internet delivered prolonged exposure (Behavioral)

Outcomes

Primary Outcomes

Number of drop-outs from treatment

Time Frame: Completion of the treatment period, up to 10 weeks

Treatment acceptability

Number of in vivo exposures made by the participant during the treatment period

Time Frame: Through the treatment period, up to 10 weeks

Number of in vivo exposures made by the participant during the treatment period

Adverse events related to the treatment

Time Frame: Through study completion, up to the 6 months follow up

Treatment acceptability

Number of imaginal exposures made by the participant during the treatment period

Time Frame: Through the treatment period, up to 10 weeks

Number of imaginal exposures made by the participant during the treatment

The proportion of participants that conducts the weekly measures and further assessment points

Time Frame: Through study completion up to the 6 months follow up]

The proportion of participants that conducts the weekly measures and further assessment points

Participants experience/satisfaction with treatment and assessment procedures through qualitative interviews

Time Frame: Completion of the treatment period up to the 6-month follow up

Qualitative interviews

Participants satisfaction with treatment, assessed by The Client Satisfaction Questionnaire (CSQ-8).

Time Frame: Completion of the treatment period, up to 10 weeks

The CSQ-8 yields a single score measuring a single dimension of overall satisfaction. An "overall score" is calculated by summing the score on each of the eight scale item. Scores range from 8 to 32, with higher values indicating higher satisfaction.

The proportion of participants that go through the entire treatment period

Time Frame: Completion of the treatment period, ten weeks

The proportion of participants that go through the entire treatment period

Secondary Outcomes

  • Change in PTSD symptoms as assessed by the Clinician Administered PTSD Scale (CAPS-5)(Baseline, 1 month and 6 months follow up)
  • Change in ICD-11 PTSD and complex PTSD symptoms as assessed by the International Trauma Questionnaire (ITQ).(Baseline, weekly through 10 weeks of treatment, post-treatment (immediately after treatment completion at 10 weeks), and the 1 month and 6 months follow up.)
  • Change in depressive symptoms as measured by the Patient Health Questionnaire-9 (PHQ-9)(Baseline, post-treatment (immediately after treatment completion at 10 weeks), and the 1 month and 6 months follow up.)
  • Change in PTSD symptoms as assessed by the PTSD Check List - DSM-5 (PCL-5)(Baseline, weekly through 10 weeks of treatment, post-treatment (immediately after treatment completion at 10 weeks), and the 1 month and 6 months follow up.)
  • Change in quality of life measured by Euroqol, EQ-5D(Baseline, post-treatment (immediately after treatment completion at 10 weeks), and the 1 month and 6 months follow up.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Maria Bragesjo

Principal investigator

Karolinska Institutet

Study Sites (1)

Loading locations...

Similar Trials